CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net loss	$ (8,453,392)	$ (6,857,643)
Adjustments to reconcile net loss to cash provided by operating activities
Stock based compensation expense	490,957	473,491
Depreciation and amortization	5,144,039	5,333,485
Loss (gain) on sale of assets	124,090	(31,443)
Contingent consideration reduction	0	(15,564)
Bad debt and reduction in allowance for bad debt	34,127	(389,943)
(Decrease) increase in fair value of derivative warrant liability	(1,844,369)	(331,715)
(Gain) loss on commodity derivative contracts	(4,489,355)	2,691,833
Net cash settlements on commodity derivatives	5,484,734	(3,446,274)
Amortization of debt discount and deferred costs	47,826	430,431
Changes in operating assets and liabilities, net of effect of acquisition
Accounts receivable	4,952,388	(987,778)
Inventory	3,939,674	2,212,989
Prepaid expenses	(1,477,191)	(833,485)
Accounts payable	(367,327)	(1,046,149)
Accrued expenses	(1,788,693)	(260,341)
Other assets	(446,324)	0
Net cash provided by (used in) operating activities	1,351,184	(3,058,106)
Cash flows from investing activities
Acquisition	(1,822,690)	0
Internally developed software	(49,229)	(380,216)
Purchase of fixed assets	(4,170,166)	(2,907,330)
Proceeds from sale of fixed assets	36,465	86,846
Net cash used in investing activities	(6,005,620)	(3,200,700)
Cash flows from financing activities
Payments on finance leases	(282,655)	(113,241)
Proceeds from exercise of stock options	0	7,075
Distribution VRM LA	0	(285,534)
Contributions received from redeemable noncontrolling interest	21,000,000	3,150,000
Proceeds received from issuance of common stock and warrants	0	2,216,711
Line of credit (payments) proceeds, net	(3,276,230)	1,543,003
Proceeds from note payable (includes proceeds from PPP note)	7,992,346	2,809,139
Payments on note payable	(9,325,745)	(3,514,365)
Net cash provided by financing activities	16,107,716	5,812,788
Net change in cash, cash equivalents and restricted cash	11,453,280	(446,018)
Cash, cash equivalents, and restricted cash at beginning of the period	4,199,825	2,849,831
Cash, cash equivalents, and restricted cash at end of period	15,653,105	2,403,813
SUPPLEMENTAL INFORMATION
Cash paid for interest	812,887	1,887,012
Cash paid for taxes	0	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B1 Preferred Stock	1,500,395	1,644,374
Dividends-in-kind accrued on Series B and B1 Preferred Stock	1,296,493	1,238,766
Equipment acquired under finance leases	1,017,638	621,000
Initial adjustment of carrying amount redeemable noncontrolling interests	9,091,068	970,809
Accretion of redeemable noncontrolling interest to redemption value	13,635,797	1,849,930
Series B1 Preferred Stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series B1 Preferred Stock into common stock	3,368,474	$ 149,914
Dividends-in-kind accrued on Series B and B1 Preferred Stock	$ 281,557